INTELLIA THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
INTELLIA THERAPEUTICS, INC. (NTLA) reported Increase (Decrease) in Accounts Payable of -$8.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$7.09M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.42M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $6.96M, a 384.61% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $3.46M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was $5.99M, a 11.96% decline from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $6.80M, a 169.63% increase from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was $2.52M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was -$4.58M, a 966.54% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 8 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.51M 10-Q · filed 2026-08-06 | -$1.55M derived: sum of 3 quarters · filed 2026-08-06 | $1.91M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$1.42M 10-Q · filed 2026-05-11 | $5.54M derived: sum of 2 quarters · filed 2026-05-11 | $9.00M derived: sum of 3 quarters · filed 2026-05-11 | $6.44M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $6.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.42M derived: sum of 2 quarters · filed 2026-02-26 | $7.86M derived: sum of 3 quarters · filed 2026-08-06 | $5.99M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $897.00K derived: sum of 2 quarters · filed 2026-08-06 | -$972.00K 10-Q · filed 2025-11-06 | $464.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.43M 10-Q · filed 2026-08-06 | -$3.00M derived: sum of 3 quarters · filed 2026-08-06 | -$8.55M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$1.87M 10-Q · filed 2026-05-11 | -$433.00K derived: sum of 2 quarters · filed 2026-05-11 | -$5.99M derived: sum of 3 quarters · filed 2026-05-11 | -$638.00K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.12M derived: sum of 2 quarters · filed 2026-02-26 | $1.23M derived: sum of 3 quarters · filed 2026-02-26 | $6.80M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$205.00K derived: sum of 2 quarters · filed 2025-11-06 | $5.36M 10-Q · filed 2025-11-06 | $9.30M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.92M 10-Q · filed 2025-08-07 | $14.86M derived: sum of 3 quarters · filed 2026-02-26 | $7.15M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $5.57M 10-Q · filed 2025-05-08 | $9.51M derived: sum of 2 quarters · filed 2026-02-26 | $1.80M derived: sum of 3 quarters · filed 2026-02-26 | $6.92M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.77M derived: sum of 2 quarters · filed 2026-02-26 | $1.35M derived: sum of 3 quarters · filed 2026-02-26 | $2.52M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$7.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.59M derived: sum of 2 quarters · filed 2024-11-07 | -$1.42M 10-Q · filed 2024-11-07 | -$669.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $5.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.29M 10-Q · filed 2024-08-08 | $7.04M derived: sum of 3 quarters · filed 2025-02-27 | $5.41M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $1.17M 10-Q · filed 2024-05-09 | $1.92M derived: sum of 2 quarters · filed 2025-02-27 | $296.00K derived: sum of 3 quarters · filed 2025-02-27 | -$3.36M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$874.00K derived: sum of 2 quarters · filed 2025-02-27 | -$4.53M derived: sum of 3 quarters · filed 2025-02-27 | -$4.58M 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$5.28M derived: sum of 2 quarters · filed 2023-11-09 | -$5.33M 10-Q · filed 2023-11-09 | -$2.94M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | -$3.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$3.71M 10-Q · filed 2023-08-03 | -$1.31M derived: sum of 3 quarters · filed 2024-02-22 | -$575.00K derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | -$57.00K 10-Q · filed 2023-05-04 | $2.34M derived: sum of 2 quarters · filed 2024-02-22 | $3.08M derived: sum of 3 quarters · filed 2024-02-22 | $1.39M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $3.13M derived: sum of 2 quarters · filed 2024-02-22 | $1.45M derived: sum of 3 quarters · filed 2024-02-22 | $529.00K 10-K · filed 2024-02-22 | |
| 2021-09-30 | $736.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$953.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.87M 10-Q · filed 2022-11-03 | -$255.00K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.61M 10-Q · filed 2022-08-04 | -$991.00K derived: sum of 3 quarters · filed 2023-02-23 | $6.35M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | -$917.00K 10-Q · filed 2022-05-05 | $698.00K derived: sum of 2 quarters · filed 2023-02-23 | $8.04M derived: sum of 3 quarters · filed 2023-02-23 | $4.51M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.96M derived: sum of 2 quarters · filed 2023-02-23 | $5.43M derived: sum of 3 quarters · filed 2023-02-23 | $5.06M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $7.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.81M derived: sum of 2 quarters · filed 2021-11-04 | $3.44M 10-Q · filed 2021-11-04 | $3.42M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | -$3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$3.90M 10-Q · filed 2021-08-05 | -$3.93M derived: sum of 3 quarters · filed 2022-02-24 | -$1.73M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | -$370.00K 10-Q · filed 2021-05-06 | -$400.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.80M derived: sum of 3 quarters · filed 2022-02-24 | $154.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.17M derived: sum of 2 quarters · filed 2022-02-24 | $524.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.88M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $554.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.91M 10-Q · filed 2020-11-05 | $2.21M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$293.00K 10-Q · filed 2020-08-06 | $4.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.54M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $1.36M 10-Q · filed 2020-05-07 | $1.65M derived: sum of 2 quarters · filed 2021-02-26 | $3.19M derived: sum of 3 quarters · filed 2021-02-26 | $1.53M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.83M derived: sum of 2 quarters · filed 2021-02-26 | $173.00K derived: sum of 3 quarters · filed 2021-02-26 | $232.00K 10-K · filed 2021-02-26 | |
| 2018-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$124.00K derived: sum of 2 quarters · filed 2019-10-31 | -$65.00K 10-Q · filed 2019-10-31 | -$321.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$1.60M 10-Q · filed 2019-08-01 | -$1.85M derived: sum of 3 quarters · filed 2020-02-27 | -$1.42M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $59.00K 10-Q · filed 2019-05-02 | -$197.00K derived: sum of 2 quarters · filed 2020-02-27 | $241.00K derived: sum of 3 quarters · filed 2020-02-27 | $525.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $182.00K derived: sum of 2 quarters · filed 2020-02-27 | $466.00K derived: sum of 3 quarters · filed 2020-02-27 | -$488.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $438.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $722.00K derived: sum of 2 quarters · filed 2018-10-31 | -$232.00K 10-Q · filed 2018-10-31 | $1.40M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$670.00K 10-Q · filed 2018-08-01 | $960.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.48M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$954.00K 10-Q · filed 2018-05-01 | $676.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.20M derived: sum of 3 quarters · filed 2019-02-27 | $917.00K derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.15M derived: sum of 2 quarters · filed 2019-02-27 | $1.87M derived: sum of 3 quarters · filed 2019-02-27 | $1.78M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $241.00K derived: sum of 2 quarters · filed 2017-10-31 | $154.00K 10-Q · filed 2017-10-31 | $84.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | -$280.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$367.00K 10-Q · filed 2017-08-01 | -$437.00K derived: sum of 3 quarters · filed 2018-03-14 | -$1.23M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | -$87.00K 10-Q · filed 2017-05-02 | -$157.00K derived: sum of 2 quarters · filed 2018-03-14 | -$949.00K derived: sum of 3 quarters · filed 2018-03-14 | -$112.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | -$70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$862.00K derived: sum of 2 quarters · filed 2018-03-14 | -$25.00K derived: sum of 3 quarters · filed 2018-03-14 | $335.00K 10-K · filed 2018-03-14 | |
| 2015-09-30 | -$792.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $45.00K derived: sum of 2 quarters · filed 2016-11-01 | $405.00K 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | $837.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.20M 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | $360.00K 10-Q · filed 2016-06-03 | ||||
| 2014-12-31 | $163.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |